Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06179706 | 11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. | completed | — | 20 | IRCCS San RaffaeleOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT02280356 | Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2024 |
| clinicaltrials |
| NCT05415787 | Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.(PROMECI) | completed | — | 40 | University Hospital, ToursOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT05797727 | Real-Life Pilot Feasibility Study (LC_RLP)(LC_RLP) | completed | N/A | 121 | Aristotle University Of ThessalonikiOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT01588262 | Early Rehabilitation of Cancer Patients | completed | N/A | 300 | Haukeland University HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT04009174 | Multi-modality Prostate Cancer Image Guided Interventions(IGPC-2) | completed | N/A | 52 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04389918 | Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer | completed | N/A | 16 | Stanford UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05326282 | Evaluating the Role of Ultrasound in Prostate Cancer(ERUP) | completed | N/A | 100 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03554317 | COMbination of Bipolar Androgen Therapy and Nivolumab(COMBAT-CRPC) | completed | Phase 2 | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03658486 | Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial(EXACT) | completed | N/A | 30 | Queen's University, BelfastOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT03388346 | 68Ga PSMA in Preprostatectomy Patients | completed | Phase 2 / Phase 3 | 22 | Michael Graham PhD, MDOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04786847 | 177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study(ProstACTSelect) | completed | Phase 1 | 30 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | Feb 12, 2024 | clinicaltrials |
| NCT00946881 | Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 30 | Steba Biotech S.A.OTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT02903160 | Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) | completed | Phase 2 | 40 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03651271 | Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer | completed | Phase 2 | 100 | Parker Institute for Cancer ImmunotherapyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04644822 | Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. | completed | Phase 3 | 100 | Centre for Probe Development and CommercializationOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04220983 | PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer(PRAGMA) | completed | N/A | 22 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06244680 | Super-fast 3T Prostate MRI Using High Gradient Strength and Deep Learning | completed | — | 77 | University Hospital, BonnOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06014853 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects | completed | Phase 1 | 48 | Bukwang PharmaceuticalINDUSTRY | 1 | Feb 5, 2024 | clinicaltrials |
| NCT03878823 | Safety and Pharmacokinetics of ODM-209(STESIDES) | completed | Phase 1 / Phase 2 | 38 | Orion Corporation, Orion PharmaINDUSTRY | 3 | Feb 1, 2024 | clinicaltrials |
| NCT00099086 | Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 1 | 20 | Medical University of South CarolinaOTHER | 0 | Jan 31, 2024 | clinicaltrials |
| NCT02543255 | Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)(ACDC-RP) | completed | Phase 2 | 76 | University Health Network, TorontoOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03698370 | Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer | completed | Phase 2 | 27 | Andrei IagaruOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03949517 | 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy | completed | Phase 1 / Phase 2 | 14 | Andrei IagaruOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT05803096 | Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | completed | Phase 4 | 143 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06131853 | Kinesiophobia in Prostate Cancer | completed | N/A | 50 | Selcuk UniversityOTHER | 1 | Jan 29, 2024 | clinicaltrials |
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer(OPT-IN) | completed | N/A | 301 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06217770 | Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment | completed | — | 237 | Chinese University of Hong KongOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers(GeneBOPP) | completed | N/A | 269 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)(ProGen) | completed | N/A | 662 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03677076 | Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer | completed | — | 14 | Medical University of South CarolinaOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04359758 | Streamlined Genetic Testing in Prostate Cancer | completed | N/A | 112 | Georgetown UniversityOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04887506 | TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer | completed | Phase 3 | 107 | Tavanta TherapeuticsINDUSTRY | 8 | Jan 16, 2024 | clinicaltrials |
| NCT04803305 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | completed | Phase 1 | 18 | PfizerINDUSTRY | 2 | Jan 12, 2024 | clinicaltrials |
| NCT01704274 | GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy(GTN) | completed | Phase 2 | 43 | Dr. D. Robert SiemensOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT03809078 | 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer | completed | Phase 2 | 14 | Andrei IagaruOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT04626466 | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation(MIFADORESOL) | completed | — | 100 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT04687709 | To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients | completed | — | 50 | Chinese University of Hong KongOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT05172986 | Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAAC(PROSTA-RAAC) | completed | N/A | 135 | ElsanOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT01013025 | Vantas Implant Retrieval Study | completed | — | 12 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 0 | Jan 2, 2024 | clinicaltrials |
| NCT01394263 | Study of Histrelin Subdermal Implant in Patients With Prostate Cancer | completed | Phase 3 | 59 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 0 | Jan 2, 2024 | clinicaltrials |
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | completed | Phase 3 | 138 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 0 | Jan 2, 2024 | clinicaltrials |
| NCT03518853 | Short Course Radiotherapy for Localized Prostate Cancer(SHORT) | completed | N/A | 30 | Tata Medical CenterOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT04867603 | Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions | completed | — | 16 | Norbert Avril, M.D.OTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT06170164 | Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes? | completed | — | 68 | IRCCS San RaffaeleOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT05773703 | Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer | completed | Early Phase 1 | 23 | Ratio Therapeutics, Inc.INDUSTRY | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06167824 | Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy | completed | — | 302 | IRCCS San RaffaeleOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06168864 | Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study. | completed | — | 350 | IRCCS San RaffaeleOTHER | 1 | Dec 13, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Mar 6, 2024source: clinicaltrials